See every side of every news story
Published loading...Updated

Modulo Bio Announces $4.8M Strategic Investment by the Alzheimer’s Drug Discovery Foundation (ADDF)

Summary by EIN Presswire
Funds will help support the development of MOD 001, a neuroimmune system modulator
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

EIN Presswire broke the news in on Wednesday, March 19, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.